<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01083797</url>
  </required_header>
  <id_info>
    <org_study_id>CEP 106/2009</org_study_id>
    <nct_id>NCT01083797</nct_id>
  </id_info>
  <brief_title>Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate</brief_title>
  <official_title>Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate: a Comparative Study of the Qualitative and Quantitative Electroencephalogram Pattern</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Santa Casa de Misericórdia de Belo Horizonte</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the use of dexmedetomidine or chloral hydrate for sedation during
      electroencephalography in patients with neurological disorders. The hypothesis is that this
      drugs provides similar changes in EEG pattern.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with chronic neurological disorders such as cerebral palsy or autism need to be
      sedated during electroencephalography (EEG). However, various sedatives and hypnotics affect
      the outcome of the review and is not shown. Chloral hydrate (CH) is widely used in children,
      but in this patients it is less effective.Recently, dexmedetomidine (DEX) has been tested
      because preliminary data suggests that this drug does not affect the EEG. The aim of the
      present work was to compare the electroencephalogram (EEG) pattern during CH or DEX sedation,
      to test the hypothesis that both drugs exert similar effects in EEG.Seventeen patients were
      evaluated during sedation with DEX or CH on separate occasions.The EEG was subjected to
      qualitative and quantitative analysis. Clinical variables were also compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>electroencephalogram pattern</measure>
    <time_frame>twenty minutes</time_frame>
    <description>Qualitative analysis: identification of the deepest phase of sleep achieved during the examination, evaluation of background activity (normal, fast activity increased or slow activity increased).
Quantitative analysis: density, duration, and amplitude of sleep spindles, spectral power and dominant frequence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effective sedative</measure>
    <time_frame>twenty minutes</time_frame>
    <description>Maintain adequate sedation permitting the completion of the examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>Two hours</time_frame>
    <description>Incidence of bradycardia, hypotension, respiratory complications and vomiting</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Other Conditions of Brain</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine, chloral hydrate</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>sedation with dexmedetomidine or chloral hydrate on separate occasions in the same patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>1 μg kg-1 infused in 10 min, and thereafter maintained from 0.2 to 0.7 μg kg-1 h- 1</description>
    <arm_group_label>dexmedetomidine, chloral hydrate</arm_group_label>
    <other_name>Dexmedetomidine: Precedex, Abbott Laboratories</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chloral Hydrate</intervention_name>
    <description>Initial dose=50 mg/kg</description>
    <arm_group_label>dexmedetomidine, chloral hydrate</arm_group_label>
    <other_name>Chloral Hydrate 10% solution (100 mg/ml)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  neurological disorder

          -  behavior disorder

          -  epilepsy

        Exclusion Criteria:

          -  cardiac disease

          -  respiratory disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magda Fernandes</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Casa de Misericórdia de Belo Horizonte</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gomez Renato</last_name>
    <role>Study Director</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Santa Casa de Belo Horizonte</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30150-221</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Lubisch N, Roskos R, Berkenbosch JW. Dexmedetomidine for procedural sedation in children with autism and other behavior disorders. Pediatr Neurol. 2009 Aug;41(2):88-94. doi: 10.1016/j.pediatrneurol.2009.02.006.</citation>
    <PMID>19589455</PMID>
  </reference>
  <reference>
    <citation>Huupponen E, Maksimow A, Lapinlampi P, Särkelä M, Saastamoinen A, Snapir A, Scheinin H, Scheinin M, Meriläinen P, Himanen SL, Jääskeläinen S. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand. 2008 Feb;52(2):289-94. Epub 2007 Nov 14.</citation>
    <PMID>18005372</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2010</study_first_submitted>
  <study_first_submitted_qc>March 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2010</study_first_posted>
  <last_update_submitted>October 24, 2013</last_update_submitted>
  <last_update_submitted_qc>October 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Renato Santiago Gomez</investigator_full_name>
    <investigator_title>Magda Lourenço Fernandes</investigator_title>
  </responsible_party>
  <keyword>Sedation</keyword>
  <keyword>Electroencephalography</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Chloral hydrate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Chloral Hydrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

